Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice
Huihui Ma, … , Suzanne Lentzsch, Markus Y. Mapara
Huihui Ma, … , Suzanne Lentzsch, Markus Y. Mapara
Published June 13, 2011
Citation Information: J Clin Invest. 2011;121(7):2554-2569. https://doi.org/10.1172/JCI43706.
View: Text | PDF | Corrigendum
Research Article Hematology Article has an altmetric score of 3

Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice

  • Text
  • PDF
Abstract

STAT1 is the main signal transducer for type I and II IFNs and plays a central role in the regulation of innate and adaptive immune responses. We used Stat1-deficient mice to test the role of donor Stat1 in MHC-matched minor histocompatibility antigen–mismatched (mHA-mismatched) and fully MHC-mismatched models of bone marrow transplantation. Lack of Stat1 in donor splenocytes reduced graft-versus-host disease (GVHD) in both immunogenetic disparities, leading to substantially attenuated morbidity and mortality. Donor Stat1 deficiency resulted in reduced alloantigen-induced activation and expansion of donor T cells and correlated with the expansion of CD4+CD25+Foxp3+ Tregs in vivo. This expansion of Tregs was further confirmed by studies showing that Stat1 deficiency promoted the proliferation, while inhibiting the apoptosis, of natural Tregs, and that absence of Stat1 enhanced the induction of inducible Tregs both in vitro and in vivo. Ex vivo expanded Stat1–/– Tregs were superior to wild-type Tregs in suppressing alloantigen-driven expansion of T cells in vitro and in inhibiting the development of GVHD. These observations demonstrate that Stat1 is a regulator of Tregs and that targeting Stat1 in CD4+ T cells may facilitate in vitro and in vivo expansion of Tregs for therapeutic use.

Authors

Huihui Ma, Caisheng Lu, Judith Ziegler, Ailing Liu, Antonia Sepulveda, Hideho Okada, Suzanne Lentzsch, Markus Y. Mapara

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 Total
Citations: 3 4 5 5 2 1 2 2 2 2 5 2 6 1 42
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (42)

Title and authors Publication Year
Janus kinase inhibition in the treatment and prevention of graft-versus-host disease
De Togni E, Cole O, Abboud R
Frontiers in immunology 2024
PCSK9 in T-cell function and the immune response
Wang Y, Fang X, Liu J, Lv X, Lu K, Lu Y, Jiang Y
Biomarker Research 2024
Increased IFN-β indicates better survival in hepatocellular carcinoma treated with radiotherapy
Zhang Y, Hong W, Zheng D, Li Z, Hu Y, Chen Y, Yang P, Zeng Z, Du S
Clinical and Experimental Immunology 2024
IFN-gamma Receptor/STAT1 Signaling in Antigen Presenting Cells Differentially Regulates Endogenous and Exogenous Antigen Presentation During Induction of Graft versus Host Disease
Caisheng Lu, Huihui Ma, Liangsong Song, Hui Wang, Lily Wang, Shirong Li, Stephen Lagana, Antonia Sepulveda, Kasper Hoebe, Yong-Guang Yang, Suzanne Lentzsch, Markus Y. Mapara
Journal of Clinical Investigation 2023
JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences.
Ott N, Faletti L, Heeg M, Andreani V, Grimbacher B
Journal of Clinical Immunology 2023
Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT
Harris R, Karimi M
Frontiers in immunology 2023
Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice
Vasquez Ayala A, Hsu CY, Oles RE, Matsuo K, Loomis LR, Buzun E, Carrillo Terrazas M, Gerner RR, Lu HH, Kim S, Zhang Z, Park JH, Rivaud P, Thomson M, Lu LF, Min B, Chu H
Journal of Experimental Medicine 2023
STAT1 signaling protects self-reactive T cells from control by innate cells during neuroinflammation
Carlos A Arbelaez, Pushpalatha Palle, Jonathan Charaix, Estelle Bettelli
JCI Insight 2022
T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
J Campe, E Ullrich
Frontiers in immunology 2022
Forward Genetics in Apicomplexa Biology: The Host Side of the Story
Sánchez-Arcila JC, Jensen KD
Frontiers in Cellular and Infection Microbiology 2022
Setd2 supports GATA3(+)ST2(+) thymic-derived Treg cells and suppresses intestinal inflammation.
Ding Z, Cai T, Tang J, Sun H, Qi X, Zhang Y, Ji Y, Yuan L, Chang H, Ma Y, Zhou H, Li L, Sheng H, Qiu J
Nature Communications 2022
S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice
Kim S, Lim S, Kim B, Ritchey J, Vij K, Prior J, Marsala L, Stoner A, Gao F, Achilefu S, Cooper ML, DiPersio JF, Choi J
Blood 2022
GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models
NJ Hess, ME Brown, CM Capitini
Frontiers in immunology 2021
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses
G Thangavelu, C Wang, M Loschi, A Saha, MJ Osborn, SN Furlan, K Aoyama, C McDonald-Hyman, EG Aguilar, AS Janesick, RA Chandraratna, Y Refaeli, A Panoskaltsis-Mortari, KP MacDonald, GR Hill, R Zeiser, I Maillard, JS Serody, WJ Murphy, DH Munn, B Blumberg, C Brown, V Kuchroo, LS Kean, KL Hippen, RJ Noelle, BR Blazar
Blood 2021
Janus Kinase Inhibitors and Cell Therapy
A Assal, MY Mapara
Frontiers in immunology 2021
Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
A Rayasam, WR Drobyski
Frontiers in immunology 2021
Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.
Alfaro R, Martínez-Banaclocha H, Llorente S, Jimenez-Coll V, Galián JA, Botella C, Moya-Quiles MR, Parrado A, Muro-Perez M, Minguela A, Legaz I, Muro M
Frontiers in immunology 2021
PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease.
Katiri Snyder, Nina C. Zitzer, Yandi Gao, Hannah K. Choe, Natalie E. Sell, Lotus Neidemire-Colley, Anora Ignaci, Charuta Kale, Raymond D. Devine, Maria G. Abad, Maciej Pietrzak, Min Wang, Hong Lin, Yang W. Zhang, Gregory K. Behbehani, Jane E. Jackman, Ramiro Garzon, Kris Vaddi, Robert A. Baiocchi, Parvathi Ranganathan
JCI Insight 2020
Human Regulatory T Cells From Umbilical Cord Blood Display Increased Repertoire Diversity and Lineage Stability Relative to Adult Peripheral Blood
K Motwani, LD Peters, WH Vliegen, AG El-sayed, HR Seay, MC Lopez, HV Baker, AL Posgai, MA Brusko, DJ Perry, R Bacher, J Larkin, MJ Haller, TM Brusko
Frontiers in immunology 2020
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
YH Kang, A Biswas, M Field, SB Snapper
Nature Communications 2019
Baricitinib-induced blockade of interferon gamma receptor and interleukin-6 receptor for the prevention and treatment of graft-versus-host disease
J Choi, ML Cooper, K Staser, K Ashami, KR Vij, B Wang, L Marsala, J Niswonger, J Ritchey, B Alahmari, S Achilefu, I Tsunoda, MA Schroeder, JF DiPersio
Leukemia 2018
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration
A Oweida, MK Hararah, A Phan, D Binder, S Bhatia, S Lennon, S Bukkapatnam, BV Court, N Uyanga, L Darragh, HM Kim, D Raben, AC Tan, L Heasley, E Clambey, R Nemenoff, SD Karam
Clinical cancer research 2018
Tbet is a critical modulator of FoxP3 expression in autoimmune graft- versus -host disease
S Amarnath, A Laurence, N Zhu, R Cunha, MA Eckhaus, S Taylor, JE Foley, M Ghosh, TC Felizardo, DH Fowler
Haematologica 2017
Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology
NK Rajasagi, S Bhela, SK Varanasi, BT Rouse
Journal of leukocyte biology 2017
Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
N Villa, M Rahman, G McFadden, C Cogle
Viruses 2016
T-bet Promotes Acute Graft-versus-Host Disease by Regulating Recipient Hematopoietic Cells in Mice
J Fu, Y Wu, H Nguyen, J Heinrichs, S Schutt, Y Liu, C Liu, J Jin, C Anasetti, XZ Yu
Journal of immunology (Baltimore, Md. : 1950) 2016
STAT1-mediated translational control in tumor suppression and antitumor therapies
S Wang, AE Koromilas
Molecular & Cellular Oncology 2015
Role of Signal Transducer and Activator of Transcription 1 in Murine Allergen–Induced Airway Remodeling and Exacerbation by Carbon Nanotubes
EA Thompson, BC Sayers, EE Glista-Baker, KA Shipkowski, MD Ihrie, KS Duke, AJ Taylor, JC Bonner
American journal of respiratory cell and molecular biology 2015
γδ T cells restrain extrathymic development of Foxp3 + -inducible regulatory T cells via IFN-γ: Immunomodulation
A Visperas, B Shen, B Min
European Journal of Immunology 2014
The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity
H Wang, YG Yang
Immunological Reviews 2014
Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation
K Murase, HT Kim, OR Bascug, Y Kawano, J Ryan, K Matsuoka, MS Davids, J Koreth, VT Ho, C Cutler, P Armand, EP Alyea, BR Blazar, JH Antin, RJ Soiffer, A Letai, J Ritz
Haematologica 2014
Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD
Christian M Capitini, Nicole M Nasholm, Christopher D Chien, Shannon M Larabee, Haiying Qin, Young K Song, Peter J Klover, Lothar Hennighausen, Javed Khan, Terry J Fry
Blood 2014
Suppressive oligodeoxynucleotides promote the generation of regulatory T cells by inhibiting STAT1 phosphorylation
C Bode, J Wang, DM Klinman
International Immunopharmacology 2014
PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD
A Ghosh, AM Holland, Y Dogan, NL Yim, UK Rao, LF Young, ML West, NV Singer, H Lee, IK Na, JJ Tsai, RR Jenq, O Penack, AM Hanash, C Lezcano, GF Murphy, C Liu, M Sadelain, MG Sauer, D Sant'angelo, MR van Brink
Cancer research 2013
Biology of Graft-versus-Host Responses: Recent Insights
KP MacDonald, WD Shlomchik, P Reddy
Biology of Blood and Marrow Transplantation 2013
Antigen presenting cell-derived complement modulates murine graft versus host disease
Wing-hong Kwan, Daigo Hashimoto, ESTELA PAZ ARTAL, Katya Ostrow, Melanie Greter, Hugo Raedler, Edward Medof, Miriam Merad, Peter S. Heeger
Journal of Clinical Investigation 2012
Advances in graft-versus-host disease biology and therapy
BR Blazar, WJ Murphy, M Abedi
Nature Reviews Immunology 2012
Targeting the interleukin-6/Jak/stat pathway in human malignancies
P Sansone, J Bromberg
Journal of Clinical Oncology 2012
Conditional Stat1 Ablation Reveals the Importance of Interferon Signaling for Immunity to Listeria monocytogenes Infection
E Kernbauer, V Maier, D Stoiber, B Strobl, C Schneckenleithner, V Sexl, U Reichart, B Reizis, U Kalinke, A Jamieson, M Müller, T Decker
PLoS pathogens 2012
IFNγR signaling mediates alloreactive T-cell trafficking and GVHD
J Choi, ED Ziga, J Ritchey, L Collins, JL Prior, ML Cooper, D Piwnica-Worms, JF DiPersio
Blood 2012
Mice deficient in STAT1 but not STAT2 or IRF9 develop a lethal CD4+ T-cell-mediated disease following infection with lymphocytic choriomeningitis virus
MJ Hofer, W Li, P Manders, R Terry, SL Lim, NJ King, IL Campbell
Journal of virology 2012
Clinical perspectives for regulatory T cells in transplantation tolerance
KL Hippen, JL Riley, CH June, BR Blazar
Seminars in Immunology 2011

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 4 X users
46 readers on Mendeley
See more details